Raymond James lowers Freeport-McMoRan stock price target to $68 By Investing.com

The market is still underestimating how much of FCX’s equity story is now a quasi-long-duration call on copper scarcity rather than a pure operating earnings story. The key second-order effect is that any incremental de-risking of Grasberg does not just protect near-term cash flow; it preserves FCX’s optionality on a structurally tight copper market where replacement capital is slow and new supply is increasingly jurisdictionally constrained. That makes the stock less sensitive to small analyst target changes than to whether the market believes the asset base can compound through the next cycle.

The bigger near-term catalyst is not the earnings beat itself, but how revisions to Grasberg guidance reshape 2026-2027 free cash flow and reserve valuation. If the market starts capitalizing those changes as a permanent impairment, FCX can de-rate even with spot copper firm, because the multiple on long-life assets compresses when investors lose confidence in terminal output. Conversely, if management can show guidance is a timing issue rather than a structural recovery problem, the stock should re-rate quickly over the next 1-3 months as sell-side NPV haircuts get reversed.

Relative winners are diversified copper substitutes and non-Indonesia levered copper exposure, while losers are investors treating FCX as a clean beta trade to copper. The contrarian angle is that the current debate may be overdone on headline jurisdictional risk: the 2018 government transaction likely reduced tail risk more than the street is giving credit for, and that lowers the probability of a true left-tail outcome. The setup favors buying volatility around guidance rather than outright chasing strength, because the stock now trades on asset durability and not just commodity prices.